Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14895464 | 0.83 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL18653753 | 0.83 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL14469398 | 0.83 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL13770693 | 0.83 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL13070334 | 0.82 | TDP1 (0.35) | TDP1TSHR | |
| SCHEMBL18934170 | 0.82 | TDP1 (0.35) | TDP1TSHR | |
| SCHEMBL19277005 | 0.82 | TDP1 (0.35) | TDP1TSHR | |
| SCHEMBL20143360 | 0.82 | TDP1 (0.35) | TDP1TSHR | |
| SCHEMBL14845686 | 0.81 | TDP1 (0.38) | TDP1TSHR | |
| SCHEMBL15357334 | 0.81 | TDP1 (0.38) | TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220081482-A1 | ANTICANCER COMPOSITIONS COMPRISING IMMUNE CHECKPOINT INHIBITORS | NOAHM INC. (KR) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220081482-A1 | ANTICANCER COMPOSITIONS COMPRISING IMMUNE CHECKPOINT INHIBITORS | ITPA, IP6K1, IP6K3 | TDP1 881/4885TSHR 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.